Focusing on the effects of combination therapy on hyperandrogenism, Jensterle et al
15 These estimates are derived from commercial net prices reflecting manufacturer discounts and rebates to align with the broader payer landscape
"Taking GLP-1s may be one of those decisions people need to discuss with their doctor, knowing that it requires a long-term commitment and may not be the best fit for those who struggle with taking medication daily or weekly." Copyright 2026 Nexstar Media, Inc
It's the mechanism
speaker/consultation fees from Lundbeck, Janssen, Alkermes, Neumora Therapeutics, Boehringer Ingelheim, Sage, Biogen, Mitsubishi Tanabe, Purdue, Pfizer, Otsuka, Takeda, Neurocrine, Sunovion, Bausch Health, Axsome, Novo Nordisk, Kris, Sanofi, Eisai, Intra-Cellular, NewBridge Pharmaceuticals, Viatris, Abbvie, Atai Life Sciences
Those taking diuretics or with baseline electrolyte abnormalities face higher dehydration risk